Recombinant Soluble Transforming Growth Factor β Type II Receptor Ameliorates Radiation Enteropathy in Mice
✍ Scribed by Huaien Zheng*; Junru Wang*; Victor E. Koteliansky†; Philip J. Gotwals†; Martin Hauer-Jensen*
- Book ID
- 119755948
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 570 KB
- Volume
- 119
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Transforming growth factor-beta (TGF-beta) is a growth modulator that inhibits the proliferation of many epithelial cells through interaction with its receptors, the type I and type II receptors (TGF-beta RI and RII) by activating their serine/threonine kinase activities. Loss of growth inhibition b
To elucidate the role of transforming growth factor-beta1 (TGF-beta1) and the TGF-beta type II receptor (TGF-beta RII) as tumor-suppressor genes in lung carcinogenesis, we mated C57BL/6 mice heterozygous (HT) for deletion of the TGF-beta1 gene with A/J mice to produce AJBL6 TGF-beta1 HT progeny and